Konstantinos Triantafyllou

Comparison of the Effects of Ramipril Versus Telmisartan in Reducing Serum Levels of High-Sensitivity C-Reactive Protein and Oxidized Low-Density Lipoprotein Cholesterol in Patients With Type 2 Diabetes Mellitus

Spyridon Koulouris, Phivos Symeonides, Konstantinos Triantafyllou et al. · The American Journal of Cardiology · 2005 · 61 citations

Metabolic Syndrome, Cardiovascular Disease, Medicine +8

“Missing” acute coronary syndrome hospitalizations during the <scp>COVID</scp>‐19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

Michail I. Papafaklis, Christos S. Katsouras, Grigorios Tsigkas et al. · Clinical Cardiology · 2020 · 55 citations · Full text

Impaired systolic dysfunction of left ventricular longitudinal fibers: A sign of early hypertensive cardiomyopathy

Spyridon Koulouris, Kostantinos G. Kostopoulos, Konstantinos Triantafyllou et al. · Clinical Cardiology · 2005 · 43 citations · Full text

Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: A comparative study

Phivos Symeonides, S KOULOURIS, Ekaterini Vratsista et al. · European Journal of Echocardiography · 2006 · 37 citations

Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement

Laurent J. Feldman, Florence Tubach, Jean‐Michel Juliard et al. · American Heart Journal · 2014 · 21 citations

Thrombosis, Percutaneous Coronary Intervention, Metabolic Syndrome +12